-The Hindu Over 1,00,000 children, below the age of 11 months, die of diarrhoea annually in India which is the second leading killer of young children globally, after pneumonia. India accounts for the highest number of diarrhoeal deaths, a latest study has suggested. A new international study published in the latest edition of the British medical journal The Lancetprovides the clearest picture yet of the impact and most common causes of diarrhoeal...

-AFP More than 300,000 babies die within 24 hours of being born in India each year from infections and other preventable causes, a report said Tuesday, blaming a lack of political will and funding for the crisis. India accounts for 29% of all newborn deaths worldwide, according to the charity ‘Save the Children' which published the findings at the launch of its annual State of the World's Mothers report. The report on 186...

-The Hindu The Union Cabinet on Wednesday approved the Rs. 22,507-crore National Urban Health Mission (NUHM) that seeks to address healthcare challenges in towns and cities with focus on urban poor. The Union Cabinet on Wednesday approved the Rs. 22,507-crore National Urban Health Mission (NUHM) that seeks to address healthcare challenges in towns and cities with focus on urban poor. The scheme will now be introduced as a sub-mission under the National...

-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...

-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...